文献速递神经肿瘤

县级地理/祖先起源对美国西班牙裔胶质瘤发病率和结局的影响

Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics.
PubMed 文献 · Neuro Oncol · 2023-01-01

美国西班牙裔胶质瘤发病率比白人非西班牙裔低25%。基于美国脑肿瘤登记数据,以墨西哥/中美洲裔为主的县胶质瘤年龄调整风险低于加勒比裔为主的县(IRR=0.83,P<0.0001),但胶质母细胞瘤患者生存更差,差异部分可由欧洲血统混杂估计解释。

要点

  • 以墨西哥/中美洲裔为主的县胶质瘤风险低于加勒比裔为主的县(IRR=0.83,P<0.0001)。
  • 墨西哥/中美洲裔为主的县胶质母细胞瘤患者生存差于加勒比裔为主的县。
  • 欧洲血统混杂与较高发病率及较好生存相关。

核心结论

  • 西班牙裔社区的地理起源与胶质瘤发病率和结局差异相关,墨西哥/中美洲裔为主的县风险显著降低,加勒比裔为主的县风险相对较高。

研究设计与样本

  • 从美国脑肿瘤中央登记处获取西班牙裔县级胶质瘤发病率数据,用美国社区调查确定县级墨西哥/中美洲裔和加勒比裔西班牙裔人口比例,采用年龄调整发病率比和发病率比(IRR)量化组间差异,州级西班牙裔血统混杂估计来自已发表的23andMe数据。

主要发现

  • 与加勒比裔为主的县相比,墨西哥/中美洲裔为主的县胶质瘤年龄调整风险较低(IRR=0.83;P<0.0001),胶质母细胞瘤(IRR=0.86;P<0.0001),弥漫性/间变性星形细胞瘤(IRR=0.78;P<0.0001),少突胶质细胞瘤(IRR=0.82;P<0.0001),室管膜瘤(IRR=0.88;P=0.012),毛细胞型星形细胞瘤(IRR=0.76;P<0.0001)。
  • 关联在儿童和成人中一致,并使用更细粒度地理区域分析时也一致。
  • 尽管胶质瘤发病率较低,来自墨西哥/中美洲裔为主县的西班牙裔胶质母细胞瘤患者生存差于居住在加勒比裔为主县的西班牙裔。
  • 发病率和生存差异可部分由州级西班牙裔欧洲血统混杂估计解释,欧洲血统混杂与较高发病率及较好生存相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioma incidence is 25% lower in Hispanics than White non-Hispanics. The US Hispanic population is diverse, and registry-based analyses may mask incidence differences associated with geographic/ancestral origins. METHODS: County-level glioma incidence data in Hispanics were retrieved from the Central Brain Tumor Registry of the United States. American Community Survey data were used to determine the county-level proportion of the Hispanic population of Mexican/Central American and Caribbean origins. Age-adjusted incidence rate ratios and incidence rate ratios (IRRs) quantified the glioma incidence differences across groups. State-level estimates of admixture in Hispanics were obtained from published 23andMe data. RESULTS: Compared to predominantly Caribbean-origin counties, predominantly Mexican/Central American-origin counties had lower age-adjusted risks of glioma (IRR = 0.83; P < 0.0001), glioblastoma (IRR = 0.86; P < 0.0001), diffuse/anaplastic astrocytoma (IRR = 0.78; P < 0.0001), oligodendroglioma (IRR = 0.82; P < 0.0001), ependymoma (IRR = 0.88; P = 0.012), and pilocytic astrocytoma (IRR = 0.76; P < 0.0001). Associations were consistent in children and adults and using more granular geographic regions. Despite having lower glioma incidence, Hispanic glioblastoma patients from predominantly Mexican/Central American-origin counties had poorer survival than Hispanics living in predominantly Caribbean-origin counties. Incidence and survival differences could be partially explained by state-level estimates of European admixture in Hispanics with European admixture associated with higher incidence and improved survival. CONCLUSIONS: Glioma incidence and outcomes differ in association with the geographic origins of Hispanic communities, with counties of predominantly Mexican/Central American origin at significantly reduced risk and those of Caribbean origin at comparatively greater risk. Although typically classified as a single ethnic group, appreciating the cultural, socioeconomic, and genetic diversity of Hispanics can advance cancer disparities research.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Walsh KM, Neff C, Bondy ML, et al. Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics. Neuro Oncol. 2023. PMID: 35868246. doi:10.1093/neuonc/noac175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。